Found: 178
Select item for more details and to access through your institution.
A Review of Pharmacogenetics of Adverse Drug Reactions in Elderly People.
- Published in:
- Drug Safety, 2012, v. 35, p. 3, doi. 10.1007/BF03319099
- By:
- Publication type:
- Article
Communicating the new pharmacovigilance landscape.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Adverse Drug Events in Older Geriatric Patients.
- Published in:
- Drug Safety, 2012, v. 35, p. 1, doi. 10.1007/BF03319098
- By:
- Publication type:
- Article
The Authors' Reply.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Internet accounts of serious adverse drug reactions: a study of experiences of Stevens-Johnson syndrome and toxic epidermal necrolysis.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Adverse Drug Events in Older Geriatric Patients.
- Published in:
- Drug Safety, 2012, v. 35, p. 89, doi. 10.1007/BF03319106
- By:
- Publication type:
- Article
The Economic Burden of Inappropriate Drug Prescribing, Lack of Adherence and Compliance, Adverse Drug Events in Older People.
- Published in:
- Drug Safety, 2012, v. 35, p. 73, doi. 10.1007/BF03319105
- By:
- Publication type:
- Article
Frailty and Safety.
- Published in:
- Drug Safety, 2012, v. 35, p. 63, doi. 10.1007/BF03319104
- By:
- Publication type:
- Article
Geriatric Conditions and the Risk of Adverse Drug Reactions in Older Adults.
- Published in:
- Drug Safety, 2012, v. 35, p. 55, doi. 10.1007/BF03319103
- By:
- Publication type:
- Article
Estimating Renal Function to Reduce the Risk of Adverse Drug Reactions.
- Published in:
- Drug Safety, 2012, v. 35, p. 47, doi. 10.1007/BF03319102
- By:
- Publication type:
- Article
Adverse Drug Events as a Cause of Hospitalization in Older Adults.
- Published in:
- Drug Safety, 2012, v. 35, p. 29, doi. 10.1007/BF03319101
- By:
- Publication type:
- Article
Explicit Criteria for Potentially Inappropriate Medications to Reduce the Risk of Adverse Drug Reactions in Elderly People.
- Published in:
- Drug Safety, 2012, v. 35, p. 21, doi. 10.1007/BF03319100
- By:
- Publication type:
- Article
Olanzapine in schizophrenia and affective disorders.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Balancing the risks and benefits of the use of over-the-counter pain medications in children.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Neuropsychiatric adverse events and oseltamivir for prophylaxis.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project).
- Published in:
- 2012
- By:
- Publication type:
- journal article
Acknowledgement.
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1081, doi. 10.2165/11641760-000000000-00000
- Publication type:
- Article
First Workshop on Computational Methods in Pharmacovigilance held during the Medical Informatics in Europe (MIE) Conference, Pisa, Italy, 29 August 2012.
- Published in:
- 2012
- Publication type:
- Abstract
Global Patterns of Adverse Drug Reactions Over a Decade Analyses of Spontaneous Reports to VigiBase™.
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1171, doi. 10.2165/11631940-000000000-00000
- By:
- Publication type:
- Article
Reasons for and time to discontinuation of rimonabant therapy: a modified prescription-event monitoring study.
- Published in:
- 2012
- By:
- Publication type:
- journal article
The Authors' Reply.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Olanzapine in Schizophrenia and Affective Disorders.
- Published in:
- 2012
- By:
- Publication type:
- Letter
The Authors' Reply.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders: A Meta-Analysis.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Neuropsychiatric Adverse Events and Oseltamivir for Prophylaxis.
- Published in:
- 2012
- By:
- Publication type:
- Letter
The globalization of risk and risk perception: why we need a new model of risk communication for vaccines.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Reasons for and Time to Discontinuation of Rimonabant Therapy A Modified Prescription-Event Monitoring Study.
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1147, doi. 10.2165/11631330-000000000-00000
- By:
- Publication type:
- Article
Focusing on Risk Communication About Medicines.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Healthcare professionals' self-reported experiences and preferences related to direct healthcare professional communications: a survey conducted in the Netherlands.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Risk perception and communication in sub-Saharan Africa.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Internet Accounts of Serious Adverse Drug Reactions A Study of Experiences of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1159, doi. 10.2165/11631950-000000000-00000
- By:
- Publication type:
- Article
Risk Communication and the Pharmaceutical Industry: what is the reality?
- Published in:
- 2012
- By:
- Publication type:
- journal article
Individual NSAIDs and Upper Gastrointestinal Complications A Systematic Review and Meta-Analysis of Observational Studies (the SOS Project).
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1127, doi. 10.2165/11633470-000000000-00000
- By:
- Publication type:
- Article
Balancing the Risks and Benefits of the Use of Over-the-Counter Pain Medications in Children.
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1119
- By:
- Publication type:
- Article
Current Challenges and Controversies in Drug-Induced Liver Injury.
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1099, doi. 10.2165/11632970-000000000-00000
- By:
- Publication type:
- Article
Suspected Herbal Hepatotoxicity Requirements for Appropriate Causality Assessment by the US Pharmacopeia.
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1091, doi. 10.2165/11631960-000000000-00000
- By:
- Publication type:
- Article
Communicating the New Pharmacovigilance Landscape.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
How to Improve Communication for the Safe Use of Medicines? Discussions on Social Marketing and Patient-Tailored Approaches at the Annual Meetings of the WHO Programme for International Drug Monitoring.
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1073, doi. 10.2165/11640530-000000000-00000
- By:
- Publication type:
- Article
Protecting the people?: risk communication and the chequered history and performance of bureaucracy.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Challenges of drug risk communications in the Philippines.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Adverse drug reactions: when the risk becomes a reality for patients.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Focusing on risk communication about medicines: why now?
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Healthcare Professionals' Self-Reported Experiences and Preferences Related to Direct Healthcare Professional Communications. A Survey Conducted in the Netherlands.
- Published in:
- Drug Safety, 2012, v. 35, n. 11, p. 1061, doi. 10.2165/11635750-000000000-00000
- By:
- Publication type:
- Article
Risk Perception and Communication in Sub-Saharan Africa.
- Published in:
- Drug Safety, 2012, v. 35, n. 11, p. 1041, doi. 10.2165/11636270-000000000-00000
- By:
- Publication type:
- Article
The Globalization of Risk and Risk Perception. Why We Need a New Model of Risk Communication for Vaccines.
- Published in:
- Drug Safety, 2012, v. 35, n. 11, p. 1053, doi. 10.2165/11635880-000000000-00000
- By:
- Publication type:
- Article
Risk Communication and the Pharmaceutical Industry. What is the Reality?
- Published in:
- Drug Safety, 2012, v. 35, n. 11, p. 1027, doi. 10.2165/11635220-000000000-00000
- By:
- Publication type:
- Article
ABSTRACTS.
- Published in:
- 2012
- Publication type:
- Abstract
Validation of Multivariate Outlier Detection Analyses Used to Identify Potential Drug-Induced Liver Injury in Clinical Trial Populations.
- Published in:
- Drug Safety, 2012, v. 35, n. 10, p. 865, doi. 10.2165/11632670-000000000-00000
- By:
- Publication type:
- Article